Cost-Effectiveness of Subcutaneous Verse Intramuscular Interferon Beta-1A In Portugal Based on the Findings of Cochrane Collaboration Review of First-Line Treatments for Relapsing-Remitting Multiple Sclerosis
Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.897
https://www.valueinhealthjournal.com/article/S1098-3015(14)02827-7/fulltext
Title :
Cost-Effectiveness of Subcutaneous Verse Intramuscular Interferon Beta-1A In Portugal Based on the Findings of Cochrane Collaboration Review of First-Line Treatments for Relapsing-Remitting Multiple Sclerosis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)02827-7&doi=10.1016/j.jval.2014.08.897
First page :
A398
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
413